Changes in the quality of cancer care as assessed through performance indicators during the first wave of the COVID-19 pandemic in 2020: a Scoping Review

Author:

Carvalho Ana SofiaORCID,Fernandes Óscar BritoORCID,de Lange MatsORCID,Lingsma HesterORCID,Klazinga NiekORCID,Kringos DionneORCID

Abstract

AbstractObjectivesSummarize performance indicators used in the literature to evaluate the impact of the COVID-19 pandemic on cancer care (January-June 2020), and to assess changes in the quality of care as assessed via selected indicators.MethodsScoping review. Indicators and their reported trends were collated following the cancer care pathway.ResultsDatabase searches retrieved 6277 articles, 838 articles met the inclusion criteria, and 135 articles were included after full-text screening, from which 917 indicators were retrieved. Indicators assessing the diagnostic process showed a decreasing trend: from 33 indicators reporting on screening, 30 (91%) signalled a decrease during the pandemic (n=30 indicators, 91%). A reduction was also observed in the number of diagnostic procedures (n=64, 58%) and in the diagnoses (n=130, 89%). The proportion of diagnoses in the emergency setting and waiting times showed an increasing trend (n=8, 89% and n=14, 56%, respectively). Nine indicators (64%) showed stability in cancer stages distribution. A decreasing trend in the proportion of earliest stage cancers was reported by 63% of indicators (n=9), and 70% (n=43) of indicators showed an increasing trend in the proportion of advanced-stage cancers. Indicators reflecting the treatment process signalled a reduction in the number of procedures: 79% (n=82) of indicators concerning surgeries, 72% (n=41) of indicators assessing trends in radiotherapy, and 93% (n=40) of indicators related to systemic therapies. Modifications in cancer treatment were frequently reported: 64% (n=195) of indicators revealed changes in treatment. Ten indicators (83%) signalled a decreasing number of hospital admissions.ConclusionHealth systems struggled to ensure continuity of cancer care. As this pandemic keeps evolving, the trends reported over the first 6 months of 2020 provide an argument to monitor these changes closely. This information needs to be transparent, standardised, and timely, allowing to monitor quality and outcomes of care during crises and inform policy responses.

Publisher

Cold Spring Harbor Laboratory

Reference173 articles.

1. World Health Organization. A year without precedent: WHO’s COVID-19 response [Internet]. [cited 2022 Feb 11]. Available from: https://www.who.int/news-room/spotlight/a-year-without-precedent-who-s-covid-19-response

2. World Health Organization. Pulse survey on continuity of essential health services during the COVID-19 pandemic - Key informant findings from 135 countries, territories and areas - Quarter 1 2021 Reporting period: 3 months preceding date of survey submission [Internet]. [cited 2022 Jan 18]. Available from: https://www.who.int/docs/default-source/coronaviruse/finalupdate_22-april-2021_summary-ppt_ehs-pulse-survey_second-round.pdf?sfvrsn=a965e121_8

3. World Health Organization. Health Topics - Cancer [Internet]. [cited 2022 Jan 25]. Available from: https://www.who.int/health-topics/cancer#tab=tab_1

4. OECD. Health at a Glance 2021: OECD Indicators, OECD Publishing, Paris. [Internet]. 2021. Available from: https://doi.org/10.1787/ae3016b9-en.

5. Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study;J Hematol OncolJ Hematol Oncol,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3